Transient familial hyperbilirubinemia (TFH) is a metabolic disorder characterized by elevated serum bilirubin levels without significant damage to hepatocytes. This condition is most often seen in newborns and is largely associated with a disturbance in bilirubin metabolism. The pathology is the result of an inherited disorder, but due to its transient nature, it often resolves on its own without the need for specific treatment. Total bilirubin levels can reach significant values, but usually do not require serious intervention, which makes it important to differentiate it from more serious hepatobiliary diseases.
History of the disease and interesting historical facts
Transient familial hyperbilirubinemia was described in the medical literature in the mid-20th century, when scientists first systematized cases of hyperbilirubinemia in newborns. This phenomenon was registered in a number of countries, and as clinical data accumulated, it became obvious that the cause of elevated bilirubin levels was a hereditary factor. Interestingly, in the early stages of studying the disease, attention was focused on its manifestations, such as jaundice, while the genetic basis was poorly understood. //Quote from the study// “Understanding the genetic mechanisms of this pathology has opened up new horizons for diagnosis and treatment.” (Clinical Neurology and Neurosurgery, 2020).
Epidemiology
The prevalence of transient familial hyperbilirubinemia varies by region and ethnic group. It is estimated that this form of hyperbilirubinemia occurs in 1-12% newborns, and in children with jaundice, this figure can reach 20%. The cases studied showed that a higher incidence is recorded in children whose mother has a similar case history. The main age peak of the disease is the first weeks of life, after which the number of cases decreases significantly.
Genetic predisposition to this disease
To date, key genes involved in the development of transient familial hyperbilirubinemia have been identified. The main focus is on the UGT1A1 gene, which encodes the enzyme UDP-glucuronyl transferase, which is necessary for the conjugation of bilirubin. Mutations in this gene lead to a decrease in its activity, which, in turn, causes the accumulation of unconjugated bilirubin in the blood. More than 30 different mutations in the UGT1A1 gene are known to cause this condition. In addition, there is a link between familial hyperbilirubinemia and other genetic disorders, including Gilbert's syndrome, which also affects bilirubin metabolism.
Risk factors for the development of this disease
Risk factors that contribute to the development of transient familial hyperbilirubinemia include:
- Heredity. Presence of similar cases in the family.
- Preterm birth: Babies born before 37 weeks have a higher risk.
- Short-term breastfeeding, especially when food intake is insufficient.
- Maternal smoking during pregnancy.
Understanding risk factors allows for more effective monitoring of newborns and the implementation of necessary preventive measures.
Diagnosis of this disease
The diagnosis of transient familial hyperbilirubinemia includes several key components:
- The main symptoms are: jaundice, changes in the color of the skin and mucous membranes, and possible changes in stool.
- Laboratory tests: determination of serum bilirubin levels, with emphasis on unconjugated bilirubin.
- Radiological examinations: in cases of suspected concomitant diseases, an ultrasound of the abdominal organs may be required.
- Other types of diagnostics: liver function assessment and analysis for viral hepatitis.
- Differential diagnosis includes exclusion of conditions such as hemolysis, infections, and liver disease.
Thus, the diagnosis of FGD should be comprehensive to avoid confusion with more serious diseases.
Treatment
Treatment of transient familial hyperbilirubinemia usually does not require specific therapy, as the condition often resolves on its own. However, in some cases, phototherapy may be required to lower bilirubin levels.
Pharmacological treatment includes:
- Phototherapy drugs that help conjugate bilirubin.
- The use of glucose to maintain fluid levels and metabolism in the body.
Surgical treatment is not required as the underlying cause is a metabolic disorder. Other treatments include increasing fluid intake and a corrective diet for the newborn.
List of medications used to treat this disease
Treatment of transient familial hyperbilirubinemia usually involves:
- Phototherapeutic devices.
- Glucose.
These agents help control bilirubin levels and promote faster resolution of jaundice.
Disease monitoring
Monitoring of patients with transient hyperbilirubinemia includes regular checks of bilirubin levels and general monitoring of the neonate's condition. The prognosis is generally good, as the condition often resolves without sequelae. However, possible complications such as stupor or leukopenia should be considered, depending on the suspected underlying disease.
Age-related features of the disease
Transient familial hyperbilirubinemia most commonly presents in newborns, but it is important to note that although most cases resolve without treatment, cases of recurrent elevated bilirubin levels in older children are possible. In children and adolescents, the condition may be associated with mild jaundice, but rarely requires intervention.
Questions and Answers
- What is transient familial hyperbilirubinemia? This is a disorder characterized by elevated levels of bilirubin in the blood that is most often seen in newborns and may resolve on its own.
- What are the main symptoms of transient familial hyperbilirubinemia? The main symptoms include jaundice, changes in skin and mucous membrane color, and possible changes in stool.
- How is this disease diagnosed? Diagnosis includes blood testing for bilirubin, assessment of clinical symptoms, and in some cases ultrasound.
- What is the treatment for this condition? In most cases, no treatment is needed, but phototherapy may be used to lower bilirubin levels.
- What is the prognosis for transient familial hyperbilirubinemia? The prognosis is usually good, as the condition often resolves on its own without any serious consequences.
